Bumrungrad International Hospital was Asia's first to earn Joint Commission International accreditation, signifying top patient safety standards. Targeted therapy may cost around A$14,700–A$26,500, typically including advanced oncology treatment personalised by IBM Watson AI. With over half its patients from 190 countries, the hospital has strong experience catering to Australians. It also offers 150+ interpreters, embassy support, and a visa extension counter, plus DNV-GL certification for infection risk control throughout treatment.